Literature DB >> 24618924

[Point-of-care testing in preclinical emergency medicine].

M Möckel1, J Searle.   

Abstract

BACKGROUND: Measurement of biological signals directly at the patient (point-of-care testing, POCT) is an established standard in emergency medicine when test results are needed quickly and within a reliable time frame or if external testing requires a disproportionate effort.
OBJECTIVES: Currently, the rapid test for β-HCG in urine and POCT measurement of lactate, blood gases, cardiac tropinin, haemoglobin, and hematocrit are well established in emergency medicine. POCT of copeptin, fatty acid-binding proteins (FABP), procalcitonin, coagulation values, natriuretic peptides, D-dimer, and toxicological substances are of future interest. In this article, the appropriate use of point-of-care testing in prehospital emergency medicine is discussed.
RESULTS: Application of POCT is dependent of the underlying conditions, the availability of appropriate devices, and of suitable reference methods in a central laboratory. In addition, economical and quality aspects play an important role.
CONCLUSION: In emergency departments, POCT is currently developing into a standard measuring method for a number of markers because hospital laboratories are increasingly being merged and consequently reduce their emergency-analytic services. In countries with a high density of hospitals, however, preclinical POCT should be reduced to the minimum necessary.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24618924     DOI: 10.1007/s00063-013-0299-y

Source DB:  PubMed          Journal:  Med Klin Intensivmed Notfmed        ISSN: 2193-6218            Impact factor:   0.840


  15 in total

Review 1.  Biomarkers in acute coronary syndrome and percutaneous coronary intervention.

Authors:  J Searle; O Danne; C Müller; M Mockel
Journal:  Minerva Cardioangiol       Date:  2011-06       Impact factor: 1.347

Review 2.  The value of biochemical markers for risk stratification prior to hospital admission in acute chest pain.

Authors:  J Herlitz; L Svensson
Journal:  Acute Card Care       Date:  2008

Review 3.  Point-of-care testing in hospitals and primary care.

Authors:  Ralf Junker; Harald Schlebusch; Peter B Luppa
Journal:  Dtsch Arztebl Int       Date:  2010-08-20       Impact factor: 5.594

Review 4.  The diagnosis and treatment of acute pulmonary embolism.

Authors:  Alexander Schellhaass; Andreas Walther; Stavros Konstantinides; Bernd W Böttiger
Journal:  Dtsch Arztebl Int       Date:  2010-08-30       Impact factor: 5.594

5.  Pre-hospital detection of acute myocardial infarction with ultra-rapid human fatty acid-binding protein (H-FABP) immunoassay.

Authors:  Patrick Ecollan; Jean-Philippe Collet; Guillaume Boon; Marie-Laure Tanguy; Marie-Laurence Fievet; Rosita Haas; Nicolas Bertho; Shidash Siami; Jean-Christophe Hubert; Pierre Coriat; Gilles Montalescot
Journal:  Int J Cardiol       Date:  2006-11-13       Impact factor: 4.164

6.  Early markers of myocardial injury: cTnI is enough.

Authors:  Tuomo Ilva; Juha Lund; Pekka Porela; Harri Mustonen; Liisa-Maria Voipio-Pulkki; Susann Eriksson; Kim Pettersson; Pirjo Tanner; Kari Pulkki
Journal:  Clin Chim Acta       Date:  2008-11-01       Impact factor: 3.786

7.  Comparability of Results between Point-of-Care and Automated Instruments to Measure B-type Natriuretic Peptide.

Authors:  Kevin Shah; Garrett J Terracciano; Kevin Jiang; Alan S Maisel; Robert L Fitzgerald
Journal:  West J Emerg Med       Date:  2010-02

8.  The role of pre-hospital blood gas analysis in trauma resuscitation.

Authors:  Milla Jousi; Janne Reitala; Vesa Lund; Ari Katila; Ari Leppäniemi
Journal:  World J Emerg Surg       Date:  2010-04-22       Impact factor: 5.469

9.  Combination of quantitative capnometry, N-terminal pro-brain natriuretic peptide, and clinical assessment in differentiating acute heart failure from pulmonary disease as cause of acute dyspnea in pre-hospital emergency setting: study of diagnostic accuracy.

Authors:  Petra Klemen; Mirjam Golub; Stefek Grmec
Journal:  Croat Med J       Date:  2009-04       Impact factor: 1.351

10.  Use of procalcitonin for the diagnosis of pneumonia in patients presenting with a chief complaint of dyspnoea: results from the BACH (Biomarkers in Acute Heart Failure) trial.

Authors:  Alan Maisel; Sean-Xavier Neath; Judd Landsberg; Christian Mueller; Richard M Nowak; W Frank Peacock; Piotr Ponikowski; Martin Möckel; Christopher Hogan; Alan H B Wu; Mark Richards; Paul Clopton; Gerasimos S Filippatos; Salvatore Di Somma; Inder Anand; Leong L Ng; Lori B Daniels; Robert H Christenson; Mihael Potocki; James McCord; Garret Terracciano; Oliver Hartmann; Andreas Bergmann; Nils G Morgenthaler; Stefan D Anker
Journal:  Eur J Heart Fail       Date:  2012-02-02       Impact factor: 15.534

View more
  1 in total

1.  A Comparison Study Between Point-of-Care Testing Systems and Central Laboratory for Determining Blood Glucose in Venous Blood.

Authors:  Huiping Wei; Fang Lan; Qitian He; Haiwei Li; Fuyong Zhang; Xue Qin; Shan Li
Journal:  J Clin Lab Anal       Date:  2016-08-25       Impact factor: 2.352

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.